Abstract Body

The two majors circulating HIV-1 clades in France, subtype B and CRF02_AG, were originally present in distinct populations, Caucasian and West African population, respectively. However, CRF02_AG is increasing among all HIV populations and several recombinant forms, 7 URF and CRF56_cpx, were already identified. In this study, we describe a new B/CRF02_AG recombinant spreading quickly and forming a recent transmission cluster among an MSM population.

Main Parisian sequence databases were screened for the new recombinant profile. For each identified patient, available sequences and clinical data were extracted. HIV subtyping was confirmed by phylogenetic analysis for protease (PR-299bps), reverse transcriptase (RT-774bps), integrase (INT-696bps) and envelope (328bps) with the LANL reference sequences dataset and using FastTree 2.1. A first analysis of recombination points was performed on available sequences with RDP4. The time of the most recent common ancestor was estimated from PR-RT using BEAST 1.8.

30 infected patients were identified so far. PR and INT clustered with CRF02_AG while RT and env clustered with subtype B. This profile and the first recombination point identified, at position 2709 (HXB2), do not correspond to previously described recombinants. No drug resistance mutation was identified. All patients formed a recent transmission cluster in PR-RT (branch support value >99% and maximum genetic distance <2.8%). Patients were diagnosed in 2013 (n=2), 2015 (7), 2016 (11), and 2017 (10). 29/30 are male, 17/18 declared a MSM route of transmission, 8/19 were diagnosed as primo-infections. Median viral loads were at 144,295 [IQR: 58,700-326,829] and 539,808 [IQR: 156,254-3,305,809] copies/mL for non-primo- and primo-infections, respectively. Only 3 patients had CD4 <100 cells/mm3. Most of these patients are living in the Eastern Paris suburb area. tMRCA analysis estimated the emergence of this cluster in July 2012.

A new CRF02_AG/B recombinant, proposed as CRF94_B02, has been identified. All detected patients so far are included in a single recent transmission cluster and were recently diagnosed, underlying the rapid spread of this strain among MSM in Paris suburb area. A full genome analysis and a research for other patients at a national scale are undergoing.